Adjuvant treatment with shenfu injection improve quality of life in chronic heart failure patients: A meta-analysis of randomized controlled trials
Objective: Shenfu Injection (SFI) derived from Shenfu decoction, has been widely used for treating heart failure in China. This meta-analysis aimed to assess the effect of SFI as an adjuvant therapy on quality of life in patients with chronic heart failure (CHF). Methods: A systematic literature sea...
Main Authors: | Junya Zhou, Songge Chen, Minghui Xu, Yali Guo, Xue Xia, Qingzhu Qin, Hongmei Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-10-01
|
Series: | Heliyon |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2405844023078027 |
Similar Items
-
Shenfu injection: a review of pharmacological effects on cardiovascular diseases
by: Fei-Fei Xu, et al.
Published: (2024-02-01) -
Efficacy and safety of Shenfu injection for the treatment of post-acute myocardial infarction heart failure: A systematic review and meta-analysis
by: Yanhua Wu, et al.
Published: (2022-11-01) -
Effect of Shenfu pretreatment on bupivacaine cardiotoxicity: An experimental study in rats
by: Qi Wang, et al.
Published: (2023-02-01) -
Impact of Shenfu injection on a composite of organ dysfunction development in critically ill patients with coronavirus disease 2019 (COVID-19): A structured summary of a study protocol for a randomized controlled trial
by: Zong-Yu Wang, et al.
Published: (2020-08-01) -
Use of levosimendan combined with Shenfu injection to treat acute heart failure patients with hypotension: a prospective randomized controlled single-blind study
by: Miaomiao Li, et al.
Published: (2022-03-01)